Sign in

Private company

Hemofarm a.d.

Serbian pharmaceutical company

Hemofarm a.d.(full legal name: Hemofarm a.d. Farmaceutsko-hemijska industrija Vršac), a member of STADA Group, is a Serbian pharmaceutical company based in Vršac, Serbia. Founded in 1960, it is one of the largest domestic producers and exporters of medicines in Serbia.2 It is part of STADA Arzneimittel.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1960Founded1
  • Industrypharmaceutical industry1
  • HeadquartersVršac1
  • Websitewww.hemofarm.com
  • Legal formjoint-stock company1

See how the biggest companies compare on our leaderboards

Hemofarm a.d. (full legal name: Hemofarm a.d. Farmaceutsko-hemijska industrija Vršac), a member of STADA Group, is a Serbian pharmaceutical company based in Vršac, Serbia. Founded in 1960, it is one of the largest domestic producers and exporters of medicines in Serbia. Hemofarm currently operates in more than 30 countries on 3 continents and has around 3,000 employees.2

Corporate structure

Hemofarm a.d. is part of a group headed by STADA Arzneimittel. 7 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • STADA Arzneimittel Bad Vilbel, Germany
    • Hemofarm a.d. Vršac
    • Eurogenerics Subsidiary
    • Walmark Subsidiary · Třinec, Czechia
      • STADA Latvia, SIA Subsidiary · Latvia
    • EG Subsidiary · 100% · Bruxelles, Belgium
    • Stada Pharma CZ Subsidiary · Czechia
    • .stada Owned

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

The story

Hemofarm was established on 1 June 1960 in Vršac. In 2003, it opened the first factory for the production of medicine in entity Republika Srpska, Bosnia and Herzegovina. As of 2003, Hemofarm consisted of 21 subsidiaries, 12 of which were located in Serbia and the rest in Montenegro.

In 2004, the company acquired four other Serbian pharmaceutical companies, increasing its market share from 15% to 45%. As of 2011, the company had a market share in terms of production and import of 30.7%.

Hemofarm was bought by the German STADA Arzneimittel pharmaceutical group for 480 million euros in 2006. Since 9 August 2009, Hemofarm has been a member of the German STADA Group.

In August 2016, Hemofarm bought the assets of a minor Serbian pharmaceutical company, "Ivančić i sinovi", for an undisclosed amount.

From Wikipedia’s article on Hemofarm, shared under CC BY-SA 4.0.3

Products and brands

  • medication

Listed on Wikidata.1

Hemofarm’s R&D division was established in 1990, and it has been recognized by STADA as a competence center for development of new generic products not only for local and regional markets, but also for the whole STADA Group. An intensive development of products intended for registration and sale in the demanding European Union market started in 2007.

From Wikipedia’s article on Hemofarm, shared under CC BY-SA 4.0.3

Subsidiaries and ownership

Parent company

Owners

From Wikidata.1

Timeline

  1. 1960Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3